Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7691870 Benzimidazole carboxamides as raf kinase inhibitors

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 11, 2004
Date of Patent
April 6, 2010
Patent Application Number
10564184
Patent Citations Received
‌
US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor
0
‌
US Patent 11866434 Process for making a PD-1/PD-L1 inhibitor and salts and crystalline forms thereof
0
‌
US Patent 11866451 Salts and crystalline forms of a PD-1/PD-L1 inhibitor
0
‌
US Patent 11873309 Heterocyclic compounds as immunomodulators
0
‌
US Patent 11753406 Salts of a PD-1/PD-L1 inhibitor
‌
US Patent 11760756 Crystalline form of a PD-1/PD-L1 inhibitor
‌
US Patent 11780836 Process of preparing a PD-1/PD-L1 inhibitor
‌
US Patent 11787793 Heterocyclic compounds as immunomodulators
‌
US Patent 11866435 Heterocyclic compounds as immunomodulators
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7691870
Patent Primary Examiner
‌
Golam M. M. Shameem

Find more entities like US Patent 7691870 Benzimidazole carboxamides as raf kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.